C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/44 (2006.01) A61K 31/495 (2006.01) C07D 401/00 (2006.01) C07D 403/00 (2006.01)
Patent
CA 2208073
The invention covers a novel series of .alpha.-substituted hydrazides that inhibit both calpain I and calpain II. They are non-peptide irreversible active site inhibitors of calpain. The compounds are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders, brain injury, spinal cord, and peripheral nerve injury, cardiac infarction, cataracts, inflammation, restenosis, muscular dystrophy, and platelet aggregation. Pharmaceutical compositions, methods of using processes for preparing and novel intermediates useful in the processes are also disclosed.
L'invention concerne une nouvelle série d'hydrazides alpha-substitués qui inhibent à la fois la calpaïne I et la calpaïne II. Il s'agit d'inhibiteurs non peptidiques irréversibles du site actif de la calpaïne. Ces composés sont utiles dans le traitement des maladies neurodégénératives, dont les affections cérébro-vasculaires, les lésions cérébrales, les lésions de la moelle épinière et des nerfs périphériques, l'infarctus cardiaque, les cataractes, l'inflammation, la resténose, la dystrophie musculaire et l'agrégation plaquettaire. On divulgue également des compositions pharmaceutiques, des méthodes pour utiliser les procédés de préparation et de nouveaux intermédiaires utiles dans les procédés.
Wang Kevin Ka-Wang
Yuen Po-Wai
Macrae & Co.
Warner-Lambert Company
LandOfFree
Alpha-substituted hydrazides having calpain inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-substituted hydrazides having calpain inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-substituted hydrazides having calpain inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2018039